New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
04:55 EDTSI, SI, SI, THOR, THOR, THOR, STJ, STJ, STJ, ATRC, ATRC, ATRC, CADX, CADX, CADX, COV, COV, COV, CRY, CRY, CRY, EW, EW, EW, HTWR, HTWR, HTWR, ISRG, ISRG, ISRG, MDT, MDT, MDT, MYGN, MYGN, MYGN, RTIX, RTIX, RTIX, WTKWY, WTKWY, WTKWYAmerican Association for Thoracic Surgery to hold annual meeting
94th Annual Meeting of AATS is being held in Toronto on April 26-30.
News For SI;RTIX;MYGN;MDT;ISRG;HTWR;EW;CRY;COV;CADX;ATRC;STJ;THOR;WTKWY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 27, 2015
12:20 EDTSTJDeutsche Bank says would have mixed view of Abbott-St. Jude deal
Deutsche Bank analyst Kristen Stewart said she would have a "somewhat mixed" view if Abbott (ABT) were in fact to pursue a deal to buy St. Jude Medical (STJ), as was raised as a possibility by a Financial Times report this morning. Stewart said the addition of St. Jude would "significantly" improve Abbott's Device division, specifically its vascular franchise, but she adds that the $25B bid discussed in the report would be "full value" for St. Jude and wonders if such a deal would be the most efficient use of capital for a diversified company like Abbott. The analyst said her view on each stock is unchanged overall at this point and she keeps her Buy rating on Abbott and Hold rating on St. Jude.
12:07 EDTSTJAbbott bid for St. Jude doesn't seem likely, says Wells Fargo
Subscribe for More Information
11:54 EDTSTJSt. Jude Medical fades from highs, levels to watch
Subscribe for More Information
10:06 EDTSTJHigh option volume stocks
High option volume stocks: GLOG ACI NGD BEAT BAX TTPH STJ FNF SSTK
09:26 EDTSTJOn The Fly: Pre-market Movers
Subscribe for More Information
07:57 EDTSTJAbbott spokesman says company not making offer for St. Jude, Bloomberg reports
The spokesperson's statement to Bloomberg follows a report earlier this morning from Financial Times that claimed Abbott (ABT) is prepping a takeover offer for St. Jude Medical (STJ) that would value the latter at $25B.
07:51 EDTTHOR, STJThoratec volatility low into report Abbott prepping offer for St. Jude Medical
Thoratec (THOR) September call option implied volatility is at 10, October is at 6; compared to its 52-week range of 8 to 54 suggesting decreasing price movement into reports Abbott (ABT) is preparing a bid for St. Jude Medical (STJ). In July St. Jude Medical and Thoratec approved an agreement under which St. Jude Medical will acquire all of the outstanding shares of Thoratec for $63.50 per share in a cash. The deal is scheduled to close in Q4.
07:45 EDTSTJAbbott volatility up into report prepping takeover offer for St. Jude Medical
Subscribe for More Information
07:39 EDTSTJSt. Jude Medical volatility up, Abbott prepping $25B takeover offer FT reports
St. Jude Medical (STJ) September call option implied volatility is at 29, October is at 27; compared to its 52-week range of 17 to 36; suggesting slightly larger near term price movement into Abbott (ABT) is prepping a takeover offer that would value the company at $25B, sources tell The Financial Times.
06:57 EDTSTJAbbott prepping $25B takeover offer for St. Jude Medical, FT reports
Subscribe for More Information
06:56 EDTSTJAbbott prepping $25B takeover offer for St. Jude Medical, FT reports
Subscribe for More Information
August 25, 2015
09:07 EDTMDTMedtronic to acquire Twelve for $458M
In support of the company's therapy innovation strategy, Medtronic announced that it has signed a definitive agreement to acquire Twelve, a medical device company focused on the development of a transcatheter mitral valve replacement, or TMVR device. Twelve is the twelfth company spun out from the premier medical device incubator The Foundry. Medtronic has agreed to pay up to $458M for Twelve including $408M at closing and $50M on achievement of CE Marking. The cash- and debt-free transaction remains subject to customary closing conditions, and is expected to close in October 2015.
07:54 EDTSTJSt. Jude Medical management to meet with Oppenheimer
Subscribe for More Information
07:41 EDTMYGNMyriad Genetics upgraded on positive risk/reward at Wells Fargo
Subscribe for More Information
06:22 EDTMYGNMyriad Genetics upgraded to Outperform from Market Perform at Wells Fargo
Subscribe for More Information
August 24, 2015
09:45 EDTTHOROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:31 EDTSTJSt. Jude Medical receives CE Mark for MRI labeling for Prodigy MRI system
Subscribe for More Information
08:29 EDTEW, THOR, ISRGWilliam Blair to hold a field trip
Subscribe for More Information
06:39 EDTTHORThoratec downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
06:19 EDTTHORThoratec downgraded to Market Perform from Outperform at Leerink
Leerink downgraded Thoratec (THOR) to Hold from Buy ahead of the closing of its merger transaction with St. Jude Medical (STJ), which is expected to close by year-end.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use